U.S. Platelet Rich Plasma Market Size, Share & Trend Analysis By Type (Pure PRP, Leukocyte Rich PRP), By Application (Sports Medicine, Orthopedics, Dermatology, Cosmetic Surgery), By End-use, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1 Methodology and Scope
                   1.1 Market Segmentation and Scope
                       1.1.1 Segment Definitions
                           1.1.1.1 Type Segment
                           1.1.1.2 Application Segment
                           1.1.1.3 End-USE Segment
                   1.2 Estimates and Forecast Timeline
                   1.3 Information Procurement
                   1.4 Objectives
                       1.4.1 Objective - 1
                       1.4.2 Objective - 2
                       1.4.3 Objective - 3
                   1.5 Research Methodology
                   1.6 Information Procurement
                       1.6.1 Purchased Database
                       1.6.2 GVR’s Internal Database
                       1.6.3 Secondary Sources
                       1.6.4 Primary Research
                   1.7 Information or Data Analysis
                       1.7.1 Data Analysis Models
                   1.8 Market Formulation & Validation
                   1.9 Model Details
                       1.9.1 Commodity Flow Analysis
                   1.10 List of Secondary Sources
                   1.11 List of Abbreviations
Chapter 2. Executive Summary
                   2.1. Market Snapshot
                   2.2. Type, Application, and End Use Snapshot
                   2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends & Scope
                   3.1. Market Segmentation and Scope
                   3.2. Market Lineage Outlook
                       3.2.1. Parent Market Outlook
                       3.2.2. Related/Ancillary Market Outlook
                   3.3. Market Trends and Outlook
                   3.4. Market Dynamics
                       3.3.1 Increasing number of cosmetic surgery procedures
                       3.3.2 Rise in the incidence of orthopedic disorders and sports injuries
                       3.3.3 Extending medical applications of platelet rich plasma
                   3.5. Market Restraint Analysis
                       3.5.1. High costs associated with PRP products
                   3.6. Business Environment Analysis
                       3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
                       3.6.2. Porter’s Five Forces Analysis
                       3.6.3. COVID-19 Impact Analysis
Chapter 4. The U.S. Platelet Rich Plasma Market: Segment Analysis by Type, 2018 - 2030 (USD Million)
                   4.1. U.S. Platelet Rich Plasma Market: Type Movement Analysis
                   4.2. Pure PRP
                       4.2.1. The U.S. pure PRP market estimates and forecast, 2018 - 2030 (USD Million)
                   4.3. Leukocyte Rich PRP
                       4.3.1. The U.S. leukocyte rich PRP market estimates and forecast, 2018 - 2030 (USD Million)
                   4.4. Others
                       4.4.1. The U.S. other type market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 5. The U.S. Platelet Rich Plasma Market: Segment Analysis by Application, 2018 - 2030 (USD Million)
                   5.1. The U.S. Platelet Rich Plasma Market: Application Movement Analysis
                   5.2. Orthopedics
                       5.2.1. The U.S. platelet rich plasma for orthopedics market estimates and forecast, 2018 - 2030 (USD Million)
                   5.3. Sports Medicine
                       5.3.1. The U.S. platelet rich plasma for Sports Medicine market estimates and forecast, 2018 - 2030 (USD Million)
                   5.4. Cosmetic Surgery
                       5.4.1. The U.S. platelet rich plasma for cosmetic surgery market estimates and forecast, 2018 - 2030 (USD Million)
                   5.5. Dermatology
                       5.5.1. The U.S. platelet rich plasma for dermatology market estimates and forecast, 2018 - 2030 (USD Million)
                       5.5.2. The U.S. platelet rich plasma for ulcer healing dermatology market estimates and forecast, 2018 - 2030 (USD Million)
                           5.5.2.1. The U.S. platelet rich plasma for venous ulcer market estimates and forecast, 2018 - 2030 (USD Million)
                           5.5.2.2. The U.S. platelet rich plasma for traumatic ulcer market estimates and forecast, 2018 - 2030 (USD Million)
                           5.5.2.3. The U.S. platelet rich plasma for diabetic ulcer market estimates and forecast, 2018 - 2030 (USD Million)
                           5.5.2.4. The U.S. platelet rich plasma for pyoderma gangrenosum ulcer market estimates and forecast, 2018 - 2030 (USD Million)
                           5.5.2.5. The U.S. platelet rich plasma for trophic ulcer market estimates and forecast, 2018 - 2030 (USD Million)
                           5.5.2.6. The U.S. platelet rich plasma for vasculitic ulcer market estimates and forecast, 2018 - 2030 (USD Million)
                           5.5.2.7. The U.S. platelet rich plasma for other ulcer market estimates and forecast, 2018 - 2030 (USD Million)
                       5.5.3. The U.S. platelet rich plasma for other dermatology market estimates and forecast, 2018 - 2030 (USD Million)
                   5.6. Ophthalmic surgery
                       5.6.1. The U.S. platelet rich plasma for ophthalmic surgery market estimates and forecast, 2018 - 2030 (USD Million)
                   5.7. Neurosurgery
                       5.7.1. The U.S. platelet rich plasma for general surgery market estimates and forecast, 2018 - 2030 (USD Million)
                   5.8. General Surgery
                       5.8.1. The U.S. platelet rich plasma for general surgery market estimates and forecast, 2018 - 2030 (USD Million)
                   5.9. Others
                       5.9.1. The U.S. platelet rich plasma for others market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 6. The U.S. Platelet Rich Plasma Market: Segment Analysis by End Use, 2018 - 2030 (USD Million)
                   6.1. U.S. Platelet Rich Plasma Market: End Use Movement Analysis
                   6.2. Hospitals
                       6.2.1. The U.S. platelet rich plasma for hospitals market estimates and forecast, 2018 - 2030 (USD Million)
                   6.3. Clinics
                       6.3.1. The U.S. platelet rich plasma for clinics estimates and forecast, 2018 - 2030 (USD Million)
                   6.4. Others
                       6.4.1. The U.S. platelet rich plasma market for other end user estimates and forecast, 2018 - 2030 (USD Million)
Chapter 7. Company Profile
                   7.1. Company Categorization
                   7.2. Strategy Mapping
                       7.2.1. New Product Launch
                       7.2.2. Partnerships
                       7.2.3. Acquisition
                       7.2.4. Collaboration
                       7.2.5. Funding
                   7.3. Key Company Market Share Analysis, 2022
                       7.3.1. Company Profiles
                       7.3.2. Johnson & Johnson
                           7.3.2.1. Company overview
                           7.3.2.2. DePuy Synthes
                               7.3.2.2.1. Company overview
                               7.3.2.2.2. Financial Performance
                               7.3.2.2.3. Product benchmarking
                               7.3.2.2.4. Strategic initiatives
                       7.3.3. Arthrex, Inc.
                           7.3.3.1. Company overview
                           7.3.3.2. Financial Performance
                           7.3.3.3. Product benchmarking
                           7.3.3.4. Strategic initiatives
                       7.3.4. EmCyte Corporation
                           7.3.4.1. Company overview
                           7.3.4.2. Product benchmarking
                           7.3.4.3. Strategic initiatives
                       7.3.5. DR. PRP America, Llc
                           7.3.5.1. Company overview
                           7.3.5.2. Product benchmarking
                       7.3.6. Juventix
                           7.3.6.1. Company overview
                           7.3.6.2. Financial Performance
                           7.3.6.3. Product benchmarking
                       7.3.7. Terumo Corporation
                           7.3.7.1. Company overview
                           7.3.7.2. Terumo Bct, Inc.
                               7.3.7.2.1. Company overview
                               7.3.7.2.2. Financial Performance
                               7.3.7.2.3. Product benchmarking
                           7.3.7.2.4. Strategic initiatives
                       7.3.8. Zimmer Biomet
                           7.3.8.1. Company overview
                           7.3.8.2. Financial Performance
                           7.3.8.3. Product benchmarking
                           7.3.8.4. Strategic initiatives
                       7.3.9. Stryker
                           7.3.9.1. Company overview
                           7.3.9.2. Financial Performance
                           7.3.9.3. Product benchmarking
                           7.3.9.4. Strategic initiatives
                       7.3.10. Apex Biologix
                           7.3.10.1. Company overview
                           7.3.10.2. Financial Performance
                           7.3.10.3. Product benchmarking
                           7.3.10.4. Strategic initiatives
                       7.3.11. Celling Biosciences
                           7.3.11.1. Company overview
                           7.3.11.2. Financial Performance
                           7.3.11.3. Product benchmarking
                           7.3.11.4. Strategic initiatives

List of Tables

Table 1. List of abbreviation
Table 2. List of secondary sources
Table 3. The U.S. Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 4. The U.S. Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 5. The U.S. Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 U.S. Platelet Rich Plasma (PRP) Market: Market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Value chain-based sizing & forecasting
Fig. 10 Platelet rich plasma (PRP) market snapshot, 2022 (USD Million)
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Prevalence rate of arthritis in the U.S. adults, diagnosed and projected cases
Fig. 13 Incidence of arthritis in U.S., by age
Fig. 14 Common minimal invasive procedures in 2021, U.S.
Fig. 15 Market restraint relevance analysis (Current & future impact)
Fig. 16 Market opportunity relevance analysis (Current & future impact)
Fig. 17 The U.S. Platelet rich plasma (PRP) market SWOT analysis
Fig. 18 The U.S. Platelet rich plasma (PRP) market Porter’s five forces analysis
Fig. 19 The U.S. Platelet rich plasma (PRP) market: Type outlook and key takeaways
Fig. 20 The U.S. Platelet rich plasma (PRP) market: Type movement analysis
Fig. 21 The U.S. Pure PRP market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 The U.S. Leukocyte rich PRP market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 The U.S. PRP market estimates and forecast for others, 2018 - 2030 (USD Million)
Fig. 24 The U.S. Platelet rich plasma (PRP) market: Application outlook and key takeaways
Fig. 25 The U.S. Platelet rich plasma (PRP) market: Application movement analysis
Fig. 26 The U.S. Platelet rich plasma (PRP) market estimates and forecast for orthopedics, 2018 - 2030 (USD Million)
Fig. 27 The U.S. Platelet rich plasma (PRP) market estimates and forecast for sports medicine, 2018 - 2030 (USD Million)
Fig. 28 The U.S. Platelet rich plasma (PRP) market estimates and forecast for cosmetic surgery, 2018 - 2030 (USD Million)
Fig. 29 The U.S. Platelet rich plasma (PRP) market estimates and forecast for dermatology, 2018 - 2030 (USD Million)
Fig. 30 The U.S. Platelet rich plasma (PRP) market estimates and forecast for ulcer healing, 2018 - 2030 (USD Million)
Fig. 31 The U.S. Platelet rich plasma (PRP) market estimates and forecast for venous ulcers, 2018 - 2030 (USD Million)
Fig. 32 The U.S. Platelet rich plasma (PRP) market estimates and forecast for traumatic ulcers, 2018 - 2030 (USD Million)
Fig. 33 The U.S. Platelet rich plasma (PRP) market estimates and forecast for pyoderma gangrenosum ulcers, 2018 - 2030 (USD Million)
Fig. 34 The U.S. Platelet rich plasma (PRP) market estimates and forecast for diabetic ulcers, 2018 - 2030
Fig. 35 The U.S. Platelet rich plasma (PRP) market estimates and forecast for trophic ulcers, 2018 - 2030
Fig. 36 The U.S. Platelet rich plasma (PRP) Market estimates and forecast for vasculitic ulcers, 2018 - 2030 (USD Million)
Fig. 37 The U.S. Platelet rich plasma (PRP) Market estimates and forecast for ulcer healing for others, 2018 - 2030 (USD Million)
Fig. 38 The U.S. Platelet rich plasma (PRP) Market estimates and forecast for other dermatology, 2018 - 2030 (USD Million)
Fig. 39 The U.S. Platelet rich plasma (PRP) market estimates and forecast for ophthalmic surgery, 2018 - 2030 (USD Million)
Fig. 40 The U.S. Platelet rich plasma (PRP) market estimates and forecast for neurosurgery, 2018 - 2030 (USD Million)
Fig. 41 The U.S. Platelet rich plasma (PRP) market estimates and forecast for general surgery, 2018 - 2030
Fig. 42 The U.S. Platelet rich plasma (PRP) market estimates and forecast for others, 2018 - 2030 (USD Million)
Fig. 43 The U.S. Platelet rich plasma (PRP) market: End-use outlook and key takeaways
Fig. 44 The U.S. Platelet rich plasma (PRP) market: End-use movement analysis
Fig. 45 The U.S. Platelet rich plasma (PRP) market for hospitals, 2018 - 2030 (USD Million)
Fig. 46 The U.S. Platelet rich plasma (PRP) market for clinics, 2018 - 2030 (USD Million)
Fig. 47 The U.S. Platelet rich plasma (PRP) market for others, 2018 - 2030 (USD Million)
Fig. 48 Strategy framework
Fig. 49 Market participation categorization